| Opportunity ID: | 330149 |
| Opportunity Number: | NOT-EY-21-005 |
| Opportunity Title: | Notice of Intent to Publish a Funding Opportunity Announcement for Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| CFDA Number(s): | 93.867 |
| Eligible Applicants: | State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | |
| Agency Code: | HHS-NIH11 |
| Agency Name: | Department of Health and Human Services
National Institutes of Health |
| Posted Date: | Dec 01, 2020 |
| Last Updated Date: | Dec 01, 2020 |
| Estimated Synopsis Post Date: | Feb 02, 2021 |
| Fiscal Year: | 2021 |
| Award Ceiling: | |
| Award Floor: | |
| Estimated Total Program Funding: | |
| Expected Number of Awards: | |
| Description: | The NEI intends to promote a new initiative by publishing a Request for Applications (RFA) to solicit applications for research that will cooperatively and comprehensively dissect ocular surface innervation – from corneal sensation to pain circuits and tearing reflexes. This RFA aims to explore this system at three levels of analysis: morphologic, molecular, and functional. Successful projects will incorporate at least two of these three levels of analysis, and ideally all three. The premise of this RFA is that such basic biology knowledge will facilitate deeper understanding of the resultant pathobiology including neuropathic ocular pain and dry eye disease. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in February 2021 with an expected application due date in June 2021. This FOA will utilize the U01 activity code. Details of the planned FOA are provided below. |
| Version: | 1 |
